{"id":"W4285498294","doi":"10.1016/j.clml.2022.07.004","title":"Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs; AbbVie; Merck","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Internal medicine; Discontinuation; Stroke (engine); Atrial fibrillation; Lower risk; Oncology; Leukemia; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001425757,0.001265381,0.002420104,0.0009231115,0.001251592,0.0001887854,0.0006899139,0.0004492556,0.0005772769],"category_scores_gemma":[0.001007314,0.00097932,0.0006406935,0.001807029,0.0006767893,0.0003988524,0.001272962,0.0003082418,0.0002596154],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.5160893,"about_ca_system_score_gemma":0.07819591,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006621154,"about_ca_topic_score_gemma":0.002121708,"domain_scores_codex":[0.9899305,0.0007760506,0.00239724,0.002736833,0.002021483,0.002137922],"domain_scores_gemma":[0.9914677,0.003791582,0.001091328,0.001711452,0.0005550698,0.001382892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1454252,0.0004090483,0.3356688,0.000424521,0.001356712,0.0004989661,0.0007015932,0.01444797,0.00004435199,0.00002937109,0.0005555145,0.500438],"study_design_scores_gemma":[0.2448073,0.03190726,0.6344662,0.0005400965,0.001077561,0.0001824157,0.0001171041,0.07685842,0.0001642826,0.00002056518,0.008529316,0.001329379],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912924,0.0002556262,0.00002153892,0.00008619404,0.000386378,0.006676298,0.0005687549,0.0002156786,0.0004971411],"genre_scores_gemma":[0.9874535,0.0003653232,0.002057994,0.000273036,0.0009386883,0.0005918779,0.0009810244,0.0003306872,0.007007889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4991086,"threshold_uncertainty_score":0.9999939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04458121361638287,"score_gpt":0.3073229471894323,"score_spread":0.2627417335730494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}